| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +15% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +17% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,814.30 +3.50 (0.12%) | 21,361.19 | 31.51 | 5.96 | ||
PfizerPFIZER | ₹4,585.10 -24.60 (0.53%) | 21,107.32 | 28.71 | 5.02 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,947.50 +3.50 (0.05%) | 17,327.00 | 102.15 | 19.85 | ||
Natco PharmaNATCOPHARM | ₹835.30 +6.65 (0.80%) | 14,848.21 | 12.97 | 1.61 |